Immunological and Clinical Aspects Determining the Risk of Recurrence in Patients with Luminal Subtype of Breast Cancer Stages I–III. (2025). Voprosy Onkologii, 71(3), OF-2271. https://doi.org/10.37469/0507-3758-2025-71-3-OF-2271